Weight-loss jab Mounjaro outperforms rival Wegovy in major study Sunday, May 11, 2025 mounjaro wegovy weightloss obesity tirzepatide semaglutide clinicaltrial glp1 gip diabetes A groundbreaking study has found that the weight-loss drug Mounjaro (tirzepatide) helps patients lose significantly more weight than its competitor, Wegovy (semaglutide). Presented at the European Congress on Obesity in … Read More